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Background: Celiac disease can present in children and adults with a variety of manifestations including a rare
complication known as ulcerative jejunitis. The latter has been associated with refractory celiac disease in adult
onset patients. The objective of this case report is to describe the first pediatric case of ulcerative jejunitis in celiac
disease, diagnosed by capsule endoscopy, which was not associated with refractory celiac disease.
Case presentation: The 9 year old girl presented with a history of abdominal pain and vomiting. Laboratory
investigations revealed a slightly elevated IgA tissue transglutaminase antibody level in the setting of serum
IgA deficiency. Initial upper endoscopy with biopsies was not conclusive for celiac disease. Further investigations
included positive IgA anti-endomysium antibody, and positive HLA DQ2 typing. Video capsule endoscopy showed
delayed appearance of villi until the proximal to mid jejunum and jejunal mucosal ulcerations. Push enteroscopy
with biopsies subsequently confirmed the diagnosis of celiac disease and ulcerative jejunitis. Immunohistochemical
studies of the intraepithelial lymphocytes and PCR amplification revealed surface expression of CD3 and CD8 and
oligoclonal T cell populations. A repeat capsule study and upper endoscopy, 1 year and 4 years following a strict
gluten free diet showed endoscopic and histological normalization of the small bowel.
Conclusion: Ulcerative jejunitis in association with celiac disease has never previously been described in children.
Capsule endoscopy was essential to both the diagnosis of celiac disease and its associated ulcerative jejunitis. The
repeat capsule endoscopy findings, one year following institution of a gluten free diet, also suggest that ulcerative
jejunitis is not always associated with refractory celiac disease and does not necessarily dictate a poor outcome.
Keywords: Ulcerative jejunitis, Celiac disease, Pediatric, Capsule endoscopyBackground
Celiac disease (CD), or gluten-sensitive enteropathy, is
an autoimmune disorder in which genetically susceptible
individuals develop inflammatory changes in the small
intestinal mucosa following the ingestion of gluten, a
protein found in grains including wheat, rye and barley
[1]. Clinical presentations vary extensively, from patients
who are asymptomatic to those having one or more
gastrointestinal symptoms such as abdominal pain, vomit-
ing, diarrhea and bloating. Extraintestinal manifestations
may include malnutrition and growth delay in children,
osteoporosis, infertility, neurological symptoms and arth-
ritis. Ulcerative jejunitis is a rare complication of CD
typically found in adults in the 5th or 6th decade. It is
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reproduction in any medium, provided the orand the possible development of enteropathy-associated
T-cell lymphoma (EATL) [2,3]. Serological tests accurately
identify those for whom a small bowel biopsy is indicated.
The most specific serological tests available include IgA
anti-endomysium (EMA) and IgA anti-tissue transgluta-
minase (tTG). The characteristic changes seen on small
bowel biopsy include various degrees of villous atrophy
with increased intraepithelial lymphocytes (IEL) and crypt
hyperplasia, as summarized in the modified Marsh-
Oberhuber Classification criteria [4]. The classic criteria
for diagnosis of CD in a child with symptoms suggestive
of CD include the characteristic histological changes on
small bowel biopsy and clinical resolution after starting a
gluten free diet (GFD) [1]. Positive serological tests that
revert to normal following a GFD are supportive of the
diagnosis [1]. Wireless capsule endoscopy of the small
bowel (CE) is occasionally used as an adjunctive diagnostic
test and has been shown to be helpful for detecting celiac
disease [5]. CE provides high-resolution magnified views
of the small intestinal mucosa and mucosal abnormalitiesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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pattern and absence or reduced duodenal folds [6].
In this case report we present the case of a child with
ulcerative jejunitis associated with celiac disease that was
diagnosed with CE and whose clinical symptoms, histo-
logical and capsule findings eventually resolved on a GFD.
Case presentation
A 9-year-old girl was referred for assessment of a 1 year
history of episodic abdominal pain and non-bilious
vomiting. The pain was described as dull, localized to
the periumbilical area and unassociated with food. A
breath test was consistent with lactose malabsorption.
However, lactose restriction only transiently improved
symptoms. The review of systems and past medical
history were unremarkable. She denied the use medica-
tions including nonsteroidal anti-inflammatory drugs
(NSAIDS). There was no family history of celiac disease,
pancreatitis, inflammatory bowel disease, or autoimmune
disorders other than multiple sclerosis (paternal grand-
mother). Her physical exam was within normal limits with
satisfactory weight and growth parameters.
Initial laboratory investigations revealed a normal hemo-
globin and white blood cell count, erythrocyte sedimenta-
tion rate and serum albumin. Her tTG was discretely
elevated (10 U/ml; normal < 5). However, her total serum
IgA was low (<0.06 g/L; normal 0.63-3.49), whereas her
IgE was elevated (986 ug/L; normal <240).
An initial upper endoscopy revealed small apthous
ulcerations in the duodenal bulb. The second portion
of the duodenum appeared normal. One duodenal biopsy
revealed mild villous blunting and acute duodenitis, with-
out an increased IEL count. No giardia or other parasites
were seen. Two other duodenal biopsies revealed normal
villi, with moderate eosinophlic infiltration involving the
glands (40–50 eosinophils per high power field (HPF)).
The pathology report concluded that the findings were
insufficient for a diagnosis of celiac disease and that
the focal eosinophilic infiltrates were consistent with
infectious, allergic or eosinophilic gastroenteropathies.
A colonoscopy revealed mild inflammatory changes in the
terminal ileum and ileocecal valve as well as hyperemia of
the mucosa in the rectosigmoid area. Histological analysis
showed focal active ileitis, and foci of mild active colitis
with intraepithelial eosinophils. No granulomas, crypt ab-
scesses, or chronic inflammatory changes were seen. She
was given a tentative diagnosis of eosinophilic gastro-
enteritis and was treated with once daily oral montelu-
kast sodium. No sustained benefit was achieved.
In view of persistent symptoms, further investigations
were pursued, which revealed positive EMA and HLA
DQ2 typing. CE of the small bowel showed patchy villous
atrophy with delayed appearance of villi until the proximal
to mid jejunum, as well as areas with slight mucosalscalloping. Moreover, fibrin covered actively bleeding mu-
cosal ulcerations were observed in the jejunum (Figure 1).
Her tTG remained slightly elevated (7 U/ml; normal < 5).
Push enteroscopy performed 7 months following her initial
upper endoscopy, confirmed ulcerative jejunitis. Biopsies
revealed subtotal villous atrophy, crypt hyperplasia and an
IEL count of 58 lymphocytes/100 enterocytes in the second
stage of the duodenum (Marsh classification III B). Changes
in the jejunum varied from preserved villous architecture
with 82 IEL/100 enterocytes (Marsh I at 65 cm) to partial
villous atrophy and crypt hyperplasia with an IEL count of
89/100 enterocytes (Marsh III B at 95 cm), consistent with
a diagnosis of celiac disease (Figure 2).
Institution of a strict GFD for 6 months led to clinical
improvement, with considerably less pain and cessation of
vomiting. Moreover, her serum tTG normalized (<3 U/ml).
However, a repeat CE again revealed delayed appearance of
villi until the mid jejunum and mucosal ulcerations in the
proximal jejunum without active bleeding, consistent with
persistent ulcerative jejunitis. Biopsies obtained by repeat
push enteroscopy after 6 months on a GFD showed normal
villous architecture in the duodenum and jejunum down to
150 cm, with an IEL count of 12/100 enterocytes per HPF
in the duodenum (Marsh 0) and 40-46/100 per HPF in the
jejunum at 130 cm and 150 cm respectively (Marsh I). The
biopsies were subsequently sent for lymphocytic identifica-
tion and PCR amplification studies for T cell rearrangement
on fresh tissue. PCR amplification studies were also done
on paraffin embedded tissue from the samples at diagnosis.
On the sample from initial diagnosis prior to GFD, a T-cell
clonal population was observed although it stained positive
for surface expression of both CD3 and CD8 (Figure 3).
The specimen obtained after 6 months on a GFD showed
oligoclonal T-cell populations and still stained positive for
surface expression of both CD3 and CD8 (Figure 4). Since
there was definite improvement histologically, a decision
was made to continue the strict GFD and to re-evaluate by
CE and histology after another 6 months.
A third CE after 12 months on a GFD was unremarkable,
with early appearance of normal villi in the duodenum and
no evidence of ulcerative jejunitis. A duodenal biopsy now
showed well preserved villous morphology and a normal
IEL count (25 lymphocytes/100 enterocytes; CD3/CD8
positive), consistent with celiac disease in remission. A re-
cent capsule, done 4 years after diagnosis, was unremark-
able and multiple duodenal biopsies were completely
normal as well. Her tTG remained normal (<3 U/ml), her
EMA normalized and her total serum IgA remained low
(0.4gL; normal 0.82-4.57).
Discussion
Most cases of CD are easily diagnosed with routine sero-
logical tests and duodenal biopsies. Unfortunately however,
the diagnosis of celiac disease is not always straight forward.
Figure 1 WIRELESS CAPSULE ENDOSCOPY Initial Exam (Normal Diet). Findings highly suggestive of celiac disease complicated by ulcerative
jejunitis. Push enteroscopy suggested to obtain diagnosis and to rule out EATL.
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need for a small intestinal biopsy because CD occurs with
a higher frequency in individuals with selective IgA defi-
ciency, as in the present case [7]. A small percentage of pa-
tients with CD are seronegative [8]. Moreover, not all cases
of CD have the classic histological criteria. Histological
findings can vary due to patchy distribution or varying
degrees of villous atrophy [4]. Furthermore, intraepithelial
lymphocytosis, crypt hyperplasia and villous atrophy can be
seen in other conditions affecting the small bowel, such as
giardiasis, Crohn’s disease, autoimmune and allergic enter-
opathies [1,4,9]. A diagnostic dilemma arose in this case in
that the serology was borderline positive as the patientFigure 2 Histological findings on a normal diet. Histological confirmatiois IgA deficient. Additionally, the initial histopathological
findings were not conclusive for CD. We thus proceeded
with CE which revealed ulcerative jejunitis in addition to
typical changes of CD. This is consistent with the recent
study [10] showing that CE is able to accurately diagnose
villous atrophy in CD as well as complications such as
ulcerative jejunitis.
Ulcerative jejunitis is rare, but can be seen in infec-
tions, or inflammatory conditions such as Crohn’ dis-
ease or eosinophilic gastroenteritis, collagen vascular
and other immune-mediated diseases such as vasculitis,
systemic lupus erythematosis or Henoch-Schonlein pur-
pura, as well as secondary to medications such as aspirinn of celiac disease by push enteroscopy.
Figure 3 Immunohistochemical phenotyping of IELs (at 95 cm in jejunum) at time of diagnosis. Intraepithelial lymphocytosis (IEL), 89
lymphocytes/100 enterocytes with double positivity for CD3 (LEFT) and CD8 (RIGHT), and negative for CD4; consistent with Marsh III A classification.
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intussusception, immunodeficiency disorders such as
hypogammaglobulinemia or various neoplastic condi-
tions [11]. In the pediatric literature, 4 cases of ulcera-
tive jejunitis were diagnosed by CE in young children
suffering from juvenile rheumatoid arthritits, three of
which were attributed to NSAID use [12].
Among adult cases, ulcerative jejunitis is usually associ-
ated with RCD [2,3]. The definitions of RCD vary in the lit-
erature. RCD can be defined as either a primary non-
response to a GFD or a secondary form, where patients
have a relapse of their enteropathy despite a GFD [13].
Generally, RCD is diagnosed if there is no histological re-
sponse to a GFD for more than 12 months or if severe
symptoms persist necessitating intervention independent of
duration of the GFD [14,15]. In fact, it was reported that it
may take up to two years for histological recovery in a pa-
tient with uncomplicated CD on a GFD [14]. RCD is classi-
fied as types 1 and 2, depending on the surface expression
of intraepithelial T-cells [16]. In type I RCD, the IEL express
CD3, CD4 or CD8, CD103 and T-cell receptors (TCR) with
polyclonal TCR gene rearrangement. These phenotypically
normal IEL are indistinguishable from those seen in active,
uncomplicated CD. In type II RCD, IEL lack surface CD3,
CD4 or CD8, and TCR, but express intracytoplasmatic
CD3 and surface CD103. The aberrant IEL in type II RCD
are often characterized by monoclonal rearrangement ofFigure 4 Histology and immunohistochemical phenotyping of IELs (a
lymphocytosis (IEL), 40 lymphocytes/100 enterocytes with double positivity
with Marsh I classification.the TCR on the genomic level [17,18]. Such aberrant IEL
have also been reported in ulcerative jejunitis and EATL,
conditions that may co-exist or evolve from RCD [19].
These observations suggest that these disorders constitute a
spectrum with type II RCD. A pediatric case of type I RCD
was recently reported [20]. Although the clinical course is
generally benign, type I RCD is associated with an increased
risk of developing autoimmune disorders. Patients not
responding to a strict GFD may benefit from immunosup-
pressive drugs [21,22], including thioguanine [23]. Type II
RCD is associated with a risk of lymphoma and thus poten-
tially a poor prognosis. Although no treatment has been
found to be curative, chemotherapeutic agents are generally
administered [24]. In severe cases, autologous stem cell
transplantation has been employed for enteropathy associ-
ated T cell lymphoma [25].
The patient described herein is, to the best of our
knowledge, unique in presenting with ulcerative jejuni-
tis in association with CD in the pediatric age group.
Furthermore, the ulcerative jejunitis did not seem to be
associated with RCD in this particular case. We did ob-
serve resolution of the ulcerative jejunitis as well as the
enteropathy after 12 months on a GFD both histologically
as well as shown by repeat CE. Moreover, despite having
ulcerative jejunitis, she never had abnormal T-cell pheno-
types or evidence of EATL. In cases with ulcerative jejuni-
tis, with or without RCD, a phenotypical analysis of IELst 150 cm in jejunum) 6 months after starting GFD. Intraepithelial
for CD3 (LEFT) and CD8 (RIGHT), and negative for CD4; consistent
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sible, using flow cytometry in order to distinguish between
the two subtypes [26].
Conclusion
Ulcerative jejunitis in association with CD has never,
based on our review of the literature, been described in
the pediatric age group. CE was essential to establishing
the initial diagnosis of CD in this patient and in identifying
the associated ulcerative jejunitis, as well as its resolution.
CE was also very helpful in guiding the need for tissue
sampling and in following the outcome of ulcerative jeju-
nitis complicating CD after institution of a GFD. The CE
findings suggest that ulcerative jejunitis is not always asso-
ciated with RCD, and as in this case, does not necessarily
dictate a poor outcome. Further studies are needed to
evaluate the incidence and outcome of ulcerative jejunitis
and RCD in children with celiac disease.
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